3 Dimensional Sonography Imaging

Weill Cornell Medicine (WCM)

Status: Completed

Conditions: New Imaging Modality

Treatments: Other: 3D Sonography analysis

Study type: Observational

Funder types: Other

Identifiers

NCT01872559

1209013095

Details and patient eligibility

About

The study is designed to evaluate a new imaging modality, 3-dimmensional sonographic volumetric analysis, and compare it to the conventional 2-dimmensional analysis that is currently in place. Those patients who are scheduled to have an ultrasound as part of their infertility treatment will be offered the opportunity to have additional measurements done at the time of their ultrasound; these additional measurements will take less than 2 minutes and do no require any additional sonograms, tests, or interventions. All patients are eligible (oocyte donors and autologous oocyte patients) and only patients with a serum estradiol > 2000pg/ML will be enrolled in the study. After the additional measurements are obtained, the results will be digitally stored. The results of the 3D sonographic volumetric analysis will then be correlated with the patients' IVF performance.

Full description

The benefits of the study is that 3-dimensional sonographic volumetric analysis may be a superior imaging modality for sonographically assessing oocyte maturity and may lead to change in clinical practice. The lone risk of the study is rooted in protecting the patients' protected health information.

Enrollment: 2 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients (oocyte donors and autologous oocyte patients)with a serum estradiol > 2000pg/ML.

Exclusion criteria

• All patients not meeting the estradiol criteria.

Trial design

2 participants in 1 patient group

3D sonographic analysis

Description:

The study is designed to evaluate a new imaging modality, 3D sonographic volumetric analysis, and compare it to the conventional 2-dimmensional analysis that is currently in place. Those patients who are scheduled to have an ultrasound as part of their infertility treatment will be offered the opportunity to have additional measurements done at the time of their ultrasound; these additional measurements will take less than 2 minutes and do no require any additional sonograms, tests, or interventions.

Treatment:

Other: 3D Sonography analysis